iRadimed (IRMD)
(Delayed Data from NSDQ)
$42.70 USD
-0.72 (-1.66%)
Updated May 9, 2024 04:00 PM ET
After-Market: $42.72 +0.02 (0.05%) 7:28 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IRMD 42.70 -0.72(-1.66%)
Will IRMD be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for IRMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IRMD
Acadia Healthcare (ACHC) Opens Facility to Serve California
UnitedHealth (UNH) Unit Awarded a Medicaid Contract by AHCCCS
IRMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Centene's (CNC) Ambetter Enhances Offerings With Broward Health
Centene (CNC) Wins Contract From Arizona's Medicaid Agency
5 Small Hidden Gems for the Rest of 2023
Other News for IRMD
IRADIMED CORPORATION (IRMD) Q1 2024 Earnings Call Transcript
IRMD Stock Earnings: iRadimed Beats EPS, Beats Revenue for Q1 2024
IRadimed: Q1 Earnings Snapshot
IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
iRadimed Corp (IRMD) Reports Record Q1 Revenue, Surpasses Analyst Estimates